NR3C1 and acute lymphoblastic leukemia: For example, the PI3K/AKT pathway phosphorylates GR at S134, inhibiting its activity in T-ALL [11], and can phosphorylate and inhibit other apoptotic and antiproliferative pathways in B-cells [42,43,44].